Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.
Ontology highlight
ABSTRACT: The emergence of immunotherapy has provided an option of treatment methods for bladder cancer (BC). However, the beneficiaries of immunotherapy are still limited to small-scale patients, and immunotherapy-related adverse events often occur. It is a major challenge for clinical work to study the immune subtypes of BC and the molecular mechanism of immune escape, and identify the immune responders accurately. Here, we explore the immune molecular subtypes of bladder cancer and potential escape mechanisms. First, we screened the expression profiles of 303 differentially expressed immune-related genes in BC patients from the Cancer Genome Atlas (TCGA) database, and successfully identified 4 molecular subtypes of BC. By comparing the clinical characteristics, immune cells infiltration, the expr
SUBMITTER: Cao J
PROVIDER: S-EPMC8335815 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA